Lipocine Stock Odds of Future Stock Price Finishing Over 23.70
| LPCN Stock | USD 4.80 0.07 1.44% |
Lipocine |
Lipocine Target Price Odds to finish over 23.70
The tendency of Lipocine Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 23.70 or more in 90 days |
| 4.80 | 90 days | 23.70 | close to zero percent |
Based on a normal probability distribution, the odds of Lipocine to move over $ 23.70 or more in 90 days from now is close to zero percent (This Lipocine probability density function shows the probability of Lipocine Stock to fall within a particular range of prices over 90 days) . Probability of Lipocine price to stay between its current price of $ 4.80 and $ 23.70 at the end of the 90-day period is about 71.5 .
Given the investment horizon of 90 days Lipocine has a beta of -0.81. This indicates as returns on the benchmark increase, returns on holding Lipocine are expected to decrease at a much lower rate. During a bear market, however, Lipocine is likely to outperform the market. Additionally Lipocine has an alpha of 0.1526, implying that it can generate a 0.15 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Lipocine Price Density |
| Price |
Predictive Modules for Lipocine
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Lipocine. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lipocine's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Lipocine Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Lipocine is not an exception. The market had few large corrections towards the Lipocine's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Lipocine, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Lipocine within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.15 | |
β | Beta against Dow Jones | -0.81 | |
σ | Overall volatility | 0.44 | |
Ir | Information ratio | 0.02 |
Lipocine Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Lipocine for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Lipocine can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Lipocine had very high historical volatility over the last 90 days | |
| Net Loss for the year was (16.35 M) with profit before overhead, payroll, taxes, and interest of 500 K. | |
| Lipocine currently holds about 37.4 M in cash with (11.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.42. | |
| Latest headline from finance.yahoo.com: FDA Grants Fast Track Designation to Lipocine for LPCN 1148 as a Treatment for Sarcopenia in Patients with Decompensated Cirrhosis |
Lipocine Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Lipocine Stock often depends not only on the future outlook of the current and potential Lipocine's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Lipocine's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 5.3 M | |
| Cash And Short Term Investments | 22 M |
Lipocine Technical Analysis
Lipocine's future price can be derived by breaking down and analyzing its technical indicators over time. Lipocine Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Lipocine. In general, you should focus on analyzing Lipocine Stock price patterns and their correlations with different microeconomic environments and drivers.
Lipocine Predictive Forecast Models
Lipocine's time-series forecasting models is one of many Lipocine's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Lipocine's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Lipocine
Checking the ongoing alerts about Lipocine for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Lipocine help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Lipocine had very high historical volatility over the last 90 days | |
| Net Loss for the year was (16.35 M) with profit before overhead, payroll, taxes, and interest of 500 K. | |
| Lipocine currently holds about 37.4 M in cash with (11.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.42. | |
| Latest headline from finance.yahoo.com: FDA Grants Fast Track Designation to Lipocine for LPCN 1148 as a Treatment for Sarcopenia in Patients with Decompensated Cirrhosis |
Check out Lipocine Backtesting, Lipocine Valuation, Lipocine Correlation, Lipocine Hype Analysis, Lipocine Volatility, Lipocine History as well as Lipocine Performance. To learn how to invest in Lipocine Stock, please use our How to Invest in Lipocine guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lipocine. If investors know Lipocine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lipocine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.75) | Revenue Per Share 0.903 | Quarterly Revenue Growth 137.519 | Return On Assets (0.23) | Return On Equity (0.34) |
The market value of Lipocine is measured differently than its book value, which is the value of Lipocine that is recorded on the company's balance sheet. Investors also form their own opinion of Lipocine's value that differs from its market value or its book value, called intrinsic value, which is Lipocine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lipocine's market value can be influenced by many factors that don't directly affect Lipocine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lipocine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lipocine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lipocine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.